11.79BMarket Cap13.38P/E (TTM)
100.610High99.210Low1.02MVolume99.970Open99.580Pre Close102.40MTurnover0.88%Turnover Ratio13.38P/E (Static)117.60MShares100.61052wk High2.16P/B11.69BFloat Cap67.67252wk Low3.18Dividend TTM116.68MShs Float119.429Historical High3.17%Div YieldTTM1.41%Amplitude5.770Historical Low100.090Avg Price1Lot Size
Eastman Chemical Stock Forum
ColumnsToday's Pre-Market Stock Movers: ORCL, RENT, U, AKRO and More
In reaction to earnings/guidance:
• $Planet Labs PBC(PL.US)$ +11.3%,$Core & Main(CNM.US)$ +6.1%,$Regal Rexnord(RRX.US)$ +2% (reaffirms outlook),$Oracle(ORCL.US)$ +1.6%
Other news:
• $Akero Therapeutics(AKRO.US)$ +93.2% (reports Phase 2b HARMONY Study)
• $Akouos(AKUS.US)$ +10.3% (FDA clears IND application to initiate a Phase 1/2 first in human pediatric clinical trial of AK-OTOF)
• $Catalyst Pharmaceuticals(CPRX.US)$ +7.7...
ColumnsAnalysts' screen on BLCO, SNAP, TSLA, ZM and more
•$Bausch + Lomb Corp.(BLCO.US)$ Goldman Sachs analyst Amit Hazan initiated coverage of Bausch + Lomb with a Neutral rating and $22 price target, implying 22% upside potential. The analyst sees Bausch + Lomb's current offering and pipeline as positioning it well to maintain or expand share in the "attractive and durable' eye care market.
•$Steel Dynamics(STLD.US)$ Goldman Sachs analyst Emily Chieng downgraded Steel Dynamics to Neutral...
ColumnsTop upgrades and downgrades on 5/31
• $Grab Holdings(GRAB.US)$: Bernstein Upgrades to Outperform from Market Perform - PT $3.04
• $Linde(LIN.US)$: Evercore ISI Upgrades to Outperform from In Line - PT $355
• $Magellan Midstream(MMP.US)$: Wells Fargo Upgrades to Overweight from EqualWeight - PT $56 (from $54)
• $Mercury Systems(MRCY.US)$: Baird Upgrades to Outperform from Neutral - PT $72 (from $56)
• $Nurix Therapeutics(NRIX.US)$: Wells Fargo Upgrades to Overweight from EqualWeight - PT...
ColumnsToday's pre-market stock movers: PLUG, CMPI, JNJ, LMT and more
• $Checkmate Pharmaceuticals(CMPI.US)$ +331.5% (Regeneron Pharma (REGN) to acquire CMPI for $10.50/share in cash)
• $Axsome Therapeutics(AXSM.US)$ +27.9% (received and agreed to Postmarketing Requirements/Commitments proposed by the FDA with respect to the New Drug Application for its AXS-05 product candidate for the treatment of major depressive disorder)
• $Super Micro Computer(SMCI.US)$ +14.3% (earnings report)
• $Plug Power(PLUG.US)$ +9.24% (t...
ColumnsTop upgrades and downgrades on 4/19
• $TechnipFMC(FTI.US)$ : Societe Generale Upgrades to uy from Hold - PT $10
• $Lululemon Athletica(LULU.US)$ : Truist Securities Upgrades to Buy from Hold - PT $495 (from $390)
• $NorthWestern(NWE.US)$ : Barclays Upgrades to Equal Weight From Underweight - PT $62 (from $57)
• $Portland General Electric(POR.US)$ : Barclays Upgrades to EqualWeight From Underweight - PT $57 (from $53)
• $Pricesmart(PSMT.US)$ : Scotiabank Upgrades to Sector Outperform Fro...
No comment yet